AbbVie Hosts National Conclave on Diabetic Macular Edema

AbbVie India held a meeting to talk about Diabetic Macular Edema (DME), a leading cause of vision loss for people with diabetes.

Experts discussed how to improve care for DME.

They talked about challenges like lack of awareness, high treatment costs, and unequal access to care.

The focus was on helping more people get screened for DME and making treatment more accessible.

They want to ensure that everyone has access to specialized retinal care across India.

Early detection and different therapies like anti-VEGF, corticosteroid implants, and laser treatments were emphasized.

The goal is to prevent vision loss and improve outcomes for patients.